Description
DAWA Phenobarbitone Tablets are oral anticonvulsant and sedative medications formulated to effectively manage various seizure disorders and conditions requiring controlled sedation. Each tablet contains Phenobarbitone, a long-acting barbiturate known for its reliable efficacy in controlling generalized and partial seizures, as well as in providing sedation in clinical or therapeutic settings.
Supplied in a pack of 100 tablets, this formulation is ideal for long-term maintenance therapy in epilepsy and other neurological conditions, under medical supervision.
Key Features:
-
Contains Phenobarbitone – a long-acting barbiturate
-
Effective in seizure management and sedation
-
Suitable for long-term oral therapy
-
Supplied in a pack of 100 tablets
-
Manufactured by DAWA under strict GMP standards
Indications:
-
Epilepsy (generalized and focal seizures)
-
Sedation in anxiety or pre-operative procedures
-
Seizure prevention in specific medical conditions
Dosage & Administration:
To be used only as prescribed by a qualified healthcare professional. Dosage is individualized based on age, weight, and clinical condition.
Storage:
Store in a cool, dry place below 25°C. Protect from moisture and light. Keep out of reach of children.
Caution: Use only under medical supervision. Not recommended for abrupt discontinuation without a doctor’s guidance.
Reviews
There are no reviews yet.